scispace - formally typeset
N

Nan Lin

Researcher at Harvard University

Publications -  1220
Citations -  65601

Nan Lin is an academic researcher from Harvard University. The author has contributed to research in topics: Medicine & Breast cancer. The author has an hindex of 105, co-authored 687 publications receiving 54545 citations. Previous affiliations of Nan Lin include University of Michigan & Fujian Medical University.

Papers
More filters
Journal ArticleDOI

Adsorption Properties and Mechanism of Attapulgite to Graphene Oxide in Aqueous Solution

TL;DR: In this paper , the effects of different pH, adsorbent mass, GO concentration, time and temperature on the adsorption of GO by attapulgite were studied, and further explored by XRD, AFM, XPS, FTIR, TEM and SEM tests.
Journal ArticleDOI

Abstract 5257: Durable clinical and radiographic responses in a series of patients with HER2+ Breast Cancer (BC) Leptomeningeal Disease (LMD) treated with trastuzumab deruxtecan (T-DXd)

TL;DR: Durable clinical and radiographic responses in a series of patients with HER2+ Breast Cancer (BC) Leptomeningeal Disease (LMD) treated with trastuzumab deruxtecan (T-DXd) are presented to provide rationale for prospective evaluation of T- DXd in HER2- LMD patients across tumor types.
Journal ArticleDOI

The database of eye-movement measures on words in Chinese reading

TL;DR: This paper reported a database of eye-movement measures of words during Chinese sentence reading, which can reflect the complex cognitive mechanisms underlying Chinese reading and indicate the processing difficulty of Chinese words during text reading, thus providing a way to manipulate the difficulty level of Chinese texts.
Journal ArticleDOI

An endoperoxide-containing covalent organic framework as a singlet oxygen reservoir for cancer therapy.

TL;DR: In this paper , a porphyrin-based COF containing a dialkylnaphthalene derivative was constructed to deliver extracellular singlet oxygen (1O2) into cancer cells through the Diels-Alder/retro-diels-alder reaction.